当前位置:循环首页>正文

[ACC2011]Carlos E. Ruiz教授谈经导管主动脉瓣植换术研究现状

作者:  CarlosE.Ruiz   日期:2011/3/29 16:07:18

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

(1) What are the advantages and shortcomings of transcatheter aortic valve implantation compared with aortic valve replacement in setting of cardiopulmonary bypass in patients with aortic stenosis?

    <International Circulation>:  What is the latest progress in transcatheter aortic valve implantation?
    Dr Ruiz: Probably the most advanced trial in the field is due to start in Europe and also extending into the US. It is called the SURTAVI trial and basically will compare the CoreValve with surgical aortic replacement. Also the second new generation valve trial is just commencing called the PARTNER II trial which will also enroll patients who are at a much lower risk. I think it is a positive step in the right direction.
 

上一页  [1]  [2]  

版面编辑:沈会会  责任编辑:张衡



Carlos E. RuizPARTNER II 试验经导管主动脉瓣置换术TAVI

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530